The low dose colchicine after myocardial infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction

ConclusionTreatment with low dose colchicine was safe and well tolerated, but was not associated with a significantly increased likelihood of achieving a CRP level< 2 mg/L or lower absolute levels of CRP 30 days after an acute MI.
Source: American Heart Journal - Category: Cardiology Source Type: research